Summary
- Current Price
- As of today, FBRX price is $25.58, up +2.90% on
- Current Price All-Time High
- FBRX price is currently -99.62% below its historical high of $6,732.38 set on
- Market Cap
- FBRX current market cap is $320M, up +562.40% over the past 365 days
- PE Ratio
- FBRX PE ratio is unknown
- Revenue
- FBRX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for FBRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Forte Biosciences, Inc. |
| Ticker | NASDAQ: FBRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fortebiorx.com |
| Employees | 14 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $25.58 | ||
| Price, 1D Change | +2.90% | |
| $320M | ||
| - | ||
| - | ||
| 0.86 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.71 | ||
| EPS, 1Y Change | +61.26% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | TOCA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.71 | ||
| EPS Estimate | N/A | -$4.31 |
| EPS Est. Change | N/A | +8.51% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $25.58 | ||
| Price Target | - | $63.00 |
| Price Tgt. Change | - | +146.29% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$11.91 | -$12.17 | -2.13% | |
| -$4.22 | -$4.71 | -11.70% | |
| -$4.31 | N/A | +8.51% | |
| -$4.13 | N/A | +12.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +248.03% | ||
| +1.31% | ||
| +562.40% | ||
| +1,410.25% | ||
| 0.00% | ||
| 0.00% | ||
| +61.26% | ||
| +76.38% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $25.58 | ||
| $18.90 | ||
| SMA 200 vs Price | -26.10% | |
| $28.83 | ||
| SMA 50 vs Price | +12.71% | |
| 0.86 | ||
| $2.78 | ||
| 44.46 | ||
| 70.98% | ||
| 111.51% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.71 | ||
| -$64.00K | ||
| - | ||
| -$70.66M | ||
| - | ||
| -$69.38M | ||
| - | ||
| -$70.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.88 | ||
| 3.88 | ||
| - | ||
| - | ||
| 3.10 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.25 | ||
| -3.45 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $60.99M | ||
| $76.96M | ||
| $82.78M | ||
| $80.59M | ||
| $21.79M | ||
| $20.75M | ||
| $0.00 | ||
| $0.00 | ||
| $9.99M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $69.38M | ||
| $70.59M | ||
| $64.00K | ||
| $0.00 | ||
| $64.00K | ||
| $0.00 | ||
| $1.04M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$50.88M | ||
| $36.23M | ||
| $69.36M | ||
| $116.00K | ||
| -$51.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | ||
| Chardan Capital | → | |
| Guggenheim | ||
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| TD Cowen | ||
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with FBRX
FAQ
What is the ticker symbol for Forte Biosciences, Inc.?
The ticker symbol for Forte Biosciences, Inc. is NASDAQ:FBRX
Does Forte Biosciences, Inc. pay dividends?
No, Forte Biosciences, Inc. does not pay dividends
What sector is Forte Biosciences, Inc. in?
Forte Biosciences, Inc. is in the Healthcare sector
What industry is Forte Biosciences, Inc. in?
Forte Biosciences, Inc. is in the Biotechnology industry
What country is Forte Biosciences, Inc. based in?
Forte Biosciences, Inc. is headquartered in United States
When did Forte Biosciences, Inc. go public?
Forte Biosciences, Inc. initial public offering (IPO) was on April 13, 2017
Is Forte Biosciences, Inc. in the S&P 500?
No, Forte Biosciences, Inc. is not included in the S&P 500 index
Is Forte Biosciences, Inc. in the NASDAQ 100?
No, Forte Biosciences, Inc. is not included in the NASDAQ 100 index
Is Forte Biosciences, Inc. in the Dow Jones?
No, Forte Biosciences, Inc. is not included in the Dow Jones index
When was Forte Biosciences, Inc. last earnings report?
Forte Biosciences, Inc.'s most recent earnings report was on November 14, 2025
When does Forte Biosciences, Inc. report earnings?
The date for Forte Biosciences, Inc.'s next earnings report has not been announced yet
Data Sources & References
- FBRX Official Website www.fortebiorx.com
- FBRX Profile on Yahoo Finance finance.yahoo.com/quote/FBRX
- FBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fbrx